The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-Cyclohexyl-3-(4-methoxy-benzenesulfonyl)-6-oxo-hexahydro-pyrimidine-4-carboxylic acid hydroxyamide ID: ALA269019
PubChem CID: 44264036
Max Phase: Preclinical
Molecular Formula: C18H25N3O6S
Molecular Weight: 411.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(S(=O)(=O)N2CN(C3CCCCC3)C(=O)C[C@@H]2C(=O)NO)cc1
Standard InChI: InChI=1S/C18H25N3O6S/c1-27-14-7-9-15(10-8-14)28(25,26)21-12-20(13-5-3-2-4-6-13)17(22)11-16(21)18(23)19-24/h7-10,13,16,24H,2-6,11-12H2,1H3,(H,19,23)/t16-/m1/s1
Standard InChI Key: RCXJWFMVFQBLSC-MRXNPFEDSA-N
Molfile:
RDKit 2D
28 30 0 0 1 0 0 0 0 0999 V2000
2.9417 -2.2625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -1.4375 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.2375 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 -3.5042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -3.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2375 -3.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 -2.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7417 -1.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -0.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1417 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3750 -3.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -4.7375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 -1.4417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8042 -2.6792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3167 -1.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9417 -0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3167 -0.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1125 -1.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0917 -2.2667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1167 -0.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3667 -4.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0875 -3.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7042 -1.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8000 -3.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -5.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7917 -4.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 5 1 0
5 1 1 0
6 4 1 0
7 3 1 0
3 8 1 6
9 2 1 0
10 2 2 0
11 2 2 0
12 4 1 0
13 6 2 0
14 8 2 0
15 8 1 0
16 9 2 0
17 9 1 0
18 19 1 0
19 17 2 0
20 16 1 0
21 15 1 0
22 18 1 0
23 12 1 0
24 12 1 0
25 22 1 0
26 24 1 0
27 23 1 0
28 26 1 0
7 6 1 0
20 18 2 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.48Molecular Weight (Monoisotopic): 411.1464AlogP: 1.08#Rotatable Bonds: 5Polar Surface Area: 116.25Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.71CX Basic pKa: ┄CX LogP: 0.84CX LogD: 0.82Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -0.93
References 1. Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE.. (2001) Heterocycle-based MMP inhibitors with P2' substituents., 11 (8): [PMID:11327577 ] [10.1016/s0960-894x(01)00137-8 ] 2. Verma RP, Hansch C.. (2007) Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs., 15 (6): [PMID:17275314 ] [10.1016/j.bmc.2007.01.011 ]